Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

The tumor microenvironment is considered to play an important role in tumor formation and progression by providing both negative and positive signals that influence tumor cell growth. We and others have previously shown that brain tumor (glioma) formation in Nf1 genetically engineered mice requires a microenvironment composed of cells heterozygous for a targeted Nf1 mutation. Using NF1 as a model system to understand the contribution of the tumor microenvironment to glioma formation, we show that Nf1+/- brain microglia produce specific factors that promote Nf1-/- astrocyte growth in vitro and in vivo and identify hyaluronidase as one of these factors in both genetically engineered Nf1 mouse and human NF1-associated optic glioma. We further demonstrate that blocking hyaluronidase ameliorates the ability of Nf1+/- microglia to increase Nf1-/- astrocyte proliferation and that hyaluronidase increases Nf1-/- astrocyte proliferation in an MAPK-dependent fashion. Lastly, inhibiting microglia activation in genetically engineered Nf1 mice significantly reduces mouse optic glioma proliferation in vivo. Collectively, these studies identify Nf1+/- microglia as an important stromal cell type that promotes Nf1-/- astrocyte and optic glioma growth relevant to the pathogenesis of NF1-associated brain tumors and suggest that future brain therapies might be directed against paracrine factors produced by cells in the tumor microenvironment.

[1]  E. Ling,et al.  Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid , 2006, Neuroscience.

[2]  D. Ingram,et al.  Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. , 2006, Human molecular genetics.

[3]  S. Waxman,et al.  Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury , 2006, The Journal of Neuroscience.

[4]  R. Khokha,et al.  TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis , 2006, Oncogene.

[5]  R. Barbucci,et al.  Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. , 2006, Glycobiology.

[6]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[7]  D. Gutmann,et al.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation , 2005, Development.

[8]  N. Warrington,et al.  Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. , 2005, Cancer research.

[9]  T. Postolache,,et al.  Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.

[10]  M. Fehlings,et al.  Disruption of the hyaluronan‐based extracellular matrix in spinal cord promotes astrocyte proliferation , 2005, Glia.

[11]  W. Streit,et al.  Role of microglia in the central nervous system's immune response , 2005, Neurological research.

[12]  C. Lewis,et al.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.

[13]  Nico van Rooijen,et al.  Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.

[14]  Erik Sahai,et al.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.

[15]  D. Gutmann,et al.  Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. , 2005, Cancer research.

[16]  D. Gutmann,et al.  Natural history of neurofibromatosis 1–associated optic nerve glioma in mice , 2005, Annals of neurology.

[17]  D. Gutmann,et al.  Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. , 2005, Cancer research.

[18]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[19]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[20]  A. Aguzzi,et al.  IL-6 is required for glioma development in a mouse model , 2004, Oncogene.

[21]  J. Epstein,et al.  Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia , 2004, Pediatric Research.

[22]  K. North,et al.  Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. , 2004, Ophthalmology.

[23]  S. Ledbetter,et al.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism , 2004, Cancer Chemotherapy and Pharmacology.

[24]  D. Viskochil It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. , 2003, The Journal of clinical investigation.

[25]  D. Gutmann,et al.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. , 2003, Cancer research.

[26]  J. Serratosa,et al.  High‐yield isolation of murine microglia by mild trypsinization , 2003, Glia.

[27]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[28]  L. Coussens,et al.  The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.

[29]  Andrew L Kung,et al.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. King,et al.  Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome , 2003, American journal of medical genetics. Part A.

[31]  D. Gutmann,et al.  The Neurofibromatosis 1 Gene Product Neurofibromin Regulates Pituitary Adenylate Cyclase-Activating Polypeptide-Mediated Signaling in Astrocytes , 2003, The Journal of Neuroscience.

[32]  Alexandra Kretz,et al.  Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas , 2003, Annals of neurology.

[33]  T. Jacks,et al.  Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. , 2003, Genes & development.

[34]  D. Gutmann,et al.  Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). , 2002, Neurology.

[35]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[36]  S. Stylli,et al.  Overexpression of Hyaluronan Synthase-2 Reduces the Tumorigenic Potential of Glioma Cells Lacking Hyaluronidase Activity , 2002, Neurosurgery.

[37]  D. Burns,et al.  Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment , 2002, Science.

[38]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[39]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[40]  G. Tarozzo,et al.  Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain , 2002, Stroke.

[41]  Werner Paulus,et al.  Microglia promote glioma migration , 2002, Acta Neuropathologica.

[42]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[43]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[44]  G. Reichmann,et al.  Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation1 , 2001, The Journal of Immunology.

[45]  W. Roggendorf,et al.  Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.

[46]  D. Gutmann,et al.  Loss of Neurofibromin Is Associated with Activation of RAS/MAPK and PI3‐K/AKT Signaling in a Neurofibromatosis 1 Astrocytoma , 2000, Journal of neuropathology and experimental neurology.

[47]  D. Gutmann,et al.  Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas , 2000, Neuropathology and applied neurobiology.

[48]  B. Badie,et al.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.

[49]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Jacks,et al.  In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells. , 1999, Blood.

[51]  A. I. Yudin,et al.  Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. , 1999, Cancer research.

[52]  B. Badie,et al.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.

[53]  J. Friedman Epidemiology of neurofibromatosis type 1. , 1999, American journal of medical genetics.

[54]  B. R. Korf,et al.  Plexiform neurofibromas. , 1999, American journal of medical genetics.

[55]  L. Gold The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.

[56]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Jacks,et al.  Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines , 1998, The Journal of experimental medicine.

[58]  N. Block,et al.  Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. , 1997, Cancer research.

[59]  D. Louis,et al.  Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task force , 1997 .

[60]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[61]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[62]  J. Charrow,et al.  Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. , 1995, The Journal of pediatrics.

[63]  R. Bjerkvig,et al.  Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen‐presenting cells , 1994, Journal of leukocyte biology.

[64]  Jack Antel,et al.  Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro , 1994, Journal of neuropathology and experimental neurology.

[65]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[66]  A. Harris,et al.  Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.

[67]  V. Perry,et al.  Macrophages and inflammation in the central nervous system , 1993, Trends in Neurosciences.

[68]  A. Bar-Or,et al.  Biology of Adult Human Microglia in Culture: Comparisons with Peripheral Blood Monocytes and Astrocytes , 1992, Journal of neuropathology and experimental neurology.

[69]  E. Thiel,et al.  Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. , 1992, Cancer research.

[70]  R. Tamargo,et al.  Angiogenesis inhibition by minocycline. , 1991, Cancer research.

[71]  H. Moses,et al.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. , 1984, Science.